Ehling R - Search Results

1

Strong genetic evidence for association of TOR1A/TOR1B with idiopathic dystonia.

Kamm C, Asmus F, Mueller J, Mayer P, Sharma M, Muller UJ, Beckert S, Ehling R, Illig T, Wichmann HE, Poewe W, Mueller JC, Gasser T. Kamm C, et al. Among authors: ehling r. Neurology. 2006 Nov 28;67(10):1857-9. doi: 10.1212/01.wnl.0000244423.63406.17. Neurology. 2006. PMID: 17130424

2

Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.

Schmied MC, Zehetmayer S, Reindl M, Ehling R, Bajer-Kornek B, Leutmezer F, Zebenholzer K, Hotzy C, Lichtner P, Meitinger T, Wichmann HE, Illig T, Gieger C, Huber K, Khalil M, Fuchs S, Schmidt H, Auff E, Kristoferitsch W, Fazekas F, Berger T, Vass K, Zimprich A. Schmied MC, et al. Among authors: ehling r. Neurogenetics. 2012 May;13(2):181-7. doi: 10.1007/s10048-012-0316-y. Epub 2012 Mar 14. Neurogenetics. 2012. PMID: 22411505

3

Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.

Wanschitz J, Ehling R, Löscher WN, Künz B, Deisenhammer F, Kuhle J, Budka H, Reindl M, Berger T. Wanschitz J, et al. Among authors: ehling r. J Neurol. 2008 Jun;255(6):917-24. doi: 10.1007/s00415-008-0815-9. Epub 2008 Jul 11. J Neurol. 2008. PMID: 18712293

4

Selective amygdalo-hippocampectomy as a potential trigger for disease progression in multiple sclerosis.

Ehling R, Dobesberger J, Unterberger I, Benke T, Gotwald T, Ortler M, Berger T, Trinka E. Ehling R, et al. Clin Neurol Neurosurg. 2011 Feb;113(2):136-8. doi: 10.1016/j.clineuro.2010.08.004. Epub 2010 Dec 18. Clin Neurol Neurosurg. 2011. PMID: 21168954 No abstract available.

5

Month-of-birth-effect in multiple sclerosis in Austria.

Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F. Walleczek NK, et al. Among authors: ehling r. Mult Scler. 2019 Dec;25(14):1870-1877. doi: 10.1177/1352458518810924. Epub 2018 Nov 22. Mult Scler. 2019. PMID: 30463473

6

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.

Gneiss C, Reindl M, Lutterotti A, Ehling R, Egg R, Khalil M, Berger T, Deisenhammer F. Gneiss C, et al. Among authors: ehling r. Mult Scler. 2004 Oct;10(5):507-10. doi: 10.1191/1352458504ms1074oa. Mult Scler. 2004. PMID: 15471365

7

Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.

Ehling R, Lutterotti A, Wanschitz J, Khalil M, Gneiss C, Deisenhammer F, Reindl M, Berger T. Ehling R, et al. Mult Scler. 2004 Dec;10(6):601-6. doi: 10.1191/1352458504ms1100oa. Mult Scler. 2004. PMID: 15584481

8

Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.

Gneiss C, Tripp P, Ehling R, Khalil M, Lutterotti A, Egg R, Mayringer I, Künz B, Berger T, Reindl M, Deisenhammer F. Gneiss C, et al. Among authors: ehling r. J Neuroimmunol. 2006 May;174(1-2):174-9. doi: 10.1016/j.jneuroim.2006.01.017. Epub 2006 Mar 23. J Neuroimmunol. 2006. PMID: 16556466 Clinical Trial.

9

Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders.

Reindl M, Khantane S, Ehling R, Schanda K, Lutterotti A, Brinkhoff C, Oertle T, Schwab ME, Deisenhammer F, Berger T, Bandtlow CE. Reindl M, et al. Among authors: ehling r. J Neuroimmunol. 2003 Dec;145(1-2):139-47. doi: 10.1016/j.jneuroim.2003.09.010. J Neuroimmunol. 2003. PMID: 14644040

10

Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.

Kuenz B, Lutterotti A, Khalil M, Ehling R, Gneiss C, Deisenhammer F, Reindl M, Berger T. Kuenz B, et al. Among authors: ehling r. J Neuroimmunol. 2005 Oct;167(1-2):143-9. doi: 10.1016/j.jneuroim.2005.06.019. J Neuroimmunol. 2005. PMID: 16040131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page